By Robert Preidt
FRIDAY, Dec. 18, 2020 (HealthDay Information) — There is no proof of a hyperlink between COVID-19 and a severe neurological situation referred to as Guillain-Barré syndrome, British researchers say.
Guillain-Barré syndrome is a uncommon autoimmune situation that assaults the peripheral nervous system, usually inflicting numbness, weak spot and ache. In extreme circumstances, it could trigger paralysis and is typically deadly.
The precise trigger is not recognized, however the syndrome typically happens after a gastroenteritis an infection referred to as Camplylobacter, with the immune system mistakenly attacking nerves as a substitute of germs.
Earlier analysis discovered a rise in circumstances of Guillain-Barré syndrome throughout Zika virus outbreaks in Latin America, and a few research have raised concern a few potential hyperlink between COVID-19 an infection and the syndrome.
For the brand new examine, researchers from College Faculty London in contrast circumstances of Guillain-Barré in the UK between 2016 and 2019 to these through the coronavirus pandemic within the first half of 2020.
The annual incidence of sufferers with Guillain-Barré who have been handled in hospitals between 2016 and 2019 topped out at 1.88 per 100,000 individuals. Between March and Might 2020, it was 40% to 50% decrease than in the identical months of 2016 to 2019, based on the examine revealed Dec. 14 within the journal Mind.
The authors mentioned their findings contradict these of smaller research and may reassure individuals.
“The potential of SARS-CoV-2 driving a worldwide spike in GBS has been eagerly monitored with a variety of revealed small case sequence already asserting a causal hyperlink,” mentioned first writer Stephen Keddie of the Division of Neuromuscular Illness.
“Our epidemiological examine exhibits there was no elevated incidence in GBS through the first wave of COVID-19; moderately, there was a lower and subsequently no causal hyperlink of COVID-19 to GBS will be made,” he mentioned in a college information launch.
The U.S. Nationwide Institute of Neurological Problems and Stroke has extra on Guillain-Barré syndrome.
SOURCE: College Faculty London, information launch, Dec. 13, 2020